Springer Nature

ONCOLOGIE Template

Write in a clean editor, then format for ONCOLOGIE in one click — DocuGuru applies the official Springer Nature template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the ONCOLOGIE format

ONCOLOGIE is a peer-reviewed journal published by Springer Nature, covering Health, Medicine and Society, Healthcare Systems and Practices, Cancer Treatment and Pharmacology.

PublisherSpringer Nature
Reference styleSuperscript numbered (Nature)
Superscript — small raised numerals in the text
1. Smith, A., Jones, B. & Lee, C. A representative article title. ONCOLOGIE 12, 45–58 (2023).

Formats any DOI in ONCOLOGIE style. No sign-up.

Publishes research inHealth, Medicine and Society Healthcare Systems and Practices Cancer Treatment and Pharmacology Breast Cancer Treatment Studies Colorectal Cancer Treatments and Studies
ISSN1292-3818
Citation impact (2-yr)1.7
h-index21
i10-index80
Total citations3,720
Open accessYes
Top institutions publishing hereInstitut Gustave Roussy
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in ONCOLOGIE per year

116
2014
86
2015
100
2016
63
2017
26
2018
14
2019
32
2020
47
2021
61
2022
88
2023
94
2024
98
2025

Citation impact of ONCOLOGIE by publication year

101
2014
57
2015
121
2016
66
2017
17
2018
5
2019
137
2020
236
2021
602
2022
319
2023
328
2024
61
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in ONCOLOGIE

Epidemiology of Breast Cancer

Shang Chao, Dongkui Xu · 1 Jan 2022

All over the world, the most common malignancy in women is breast cancer. Breast cancer is also a significant factor of death in women. In 2020, approximately 2.3 million cases of breast cancer were newly diagnosed in women globally, and approximately 685,000 people died. Breast cancer incidence varies by region around the world, but it…

Advances in Targeted Therapy Against Driver Mutations and Epigenetic Alterations in Non-Small Cell Lung Cancer

Jiajian Shi, Yuchen Chen, Chentai Peng et al. · 1 Jan 2022

The incidence and mortality of lung cancer rank top three of all cancers worldwide. Accounting for 85% of the total number of lung cancer, non-small cell lung cancer (NSCLC) is an important factor endangering human health. Re... | Find, read and cite all the research you need on Tech Science Press

The tumor microenvironment: a key player in multidrug resistance in cancer

Lingnan Meng, Ying Zheng, Hao Liu et al. · 1 Jan 2024

Abstract Cancer is the second leading cause of death worldwide. Although multiple new cancer treatments have emerged in recent years, drug therapy, mainly comprising chemotherapy, targeted therapy, and immunotherapy, remains the most common approach. The multidrug resistance (MDR) of cancer cells to various treatments remains a challenge. Scientists have always focused on the acquired drug…

Chinese Herbal Prescription QYSL Prevents Progression of Lung Cancer by Targeting Tumor Microenvironment

Yang Chen, Huan Wu, Annan Jiao et al. · 1 Jan 2022

Objectives: Lung cancer is a common and malignant tumor in adults and ranks first in the incidence and mortality of the top five malignant tumors in China. Our previous studies have shown that QYSL prescription can balance lung cancer mice Th1/Th2 and inhibit tumor cell immune escape. Here, we examined the effects of QYSL on…

Gene Editing in Non-Small Cell Lung Cancer: Current Application and Future Perspective

Hang‐Xing Wang, Jingyun Fang, Yujiao Wang et al. · 1 Jan 2022

Lung cancer is the most common malignant tumor with the highest morbidity and mortality in the world, and non-small cell lung cancer (NSCLC) accounts for the vast majority of cases. At present, its main treatment methods are still traditional surgery, radiotherapy and chemotherapy, with disadvantages such as a high recurrence rate and limited effectiveness. Therefore,…

ONCOLOGIE template — frequently asked questions

How do I write a paper in the ONCOLOGIE format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the ONCOLOGIE template. When you export, DocuGuru compiles the paper into the official Springer Nature format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does ONCOLOGIE use?
ONCOLOGIE uses Superscript numbered (Nature) references, shown as superscript numerals in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: 1. Smith, A., Jones, B. & Lee, C. A representative article title. ONCOLOGIE 12, 45–58 (2023).
Do I need to know LaTeX to submit to ONCOLOGIE?
No. DocuGuru generates the sn-jnl LaTeX class and compiles the PDF for you in the background, so you get a Springer Nature-ready ONCOLOGIE document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the ONCOLOGIE template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the ONCOLOGIE format with correct headings, figures, tables, and superscript citations.
Who publishes ONCOLOGIE?
ONCOLOGIE is a multidisciplinary journal published by Springer Nature. DocuGuru's ONCOLOGIE template matches Springer Nature's official submission format.
Can I export a submission-ready ONCOLOGIE PDF?
Yes — DocuGuru produces a PDF built with the official ONCOLOGIE template (the sn-jnl class) that is ready to submit to Springer Nature, together with the matching LaTeX source files.
How much does the ONCOLOGIE template cost?
You can start writing in the ONCOLOGIE template for free. Exporting the final submission-ready ONCOLOGIE PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the ONCOLOGIE template